Universe · entity
Caligan Partners LP
Institutional manager (13F) · CIK 1727492
13F holdings · as of 2026-03-31 · top 24 · reported portfolio $1.4B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | $306M | 8,118,892 |
| 2 | ABIVAX SA | $163M | 1,461,924 |
| 3 | REVOLUTION MEDICINES INC | $161M | 1,652,808 |
| 4 | VAXCYTE INC | $120M | 2,060,719 |
| 5 | XENON PHARMACEUTICALS INC | $81M | 1,393,027 |
| 6 | MINERALYS THERAPEUTICS INC | $75M | 2,772,654 |
| 7 | EXELIXIS INC | $67M | 1,553,262 |
| 8 | TANGO THERAPEUTICS INC | $50M | 2,408,798 |
| 9 | TYRA BIOSCIENCES INC | $49M | 1,276,968 |
| 10 | SPYRE THERAPEUTICS INC | $44M | 878,127 |
| 11 | ADMA BIOLOGICS INC | $43M | 4,756,511 |
| 12 | LB PHARMACEUTICALS INC | $35M | 1,438,070 |
| 13 | VOR BIOPHARMA INC | $34M | 1,925,066 |
| 14 | SAB BIOTHERAPEUTICS INC | $31M | 7,967,207 |
| 15 | OPUS GENETICS INC | $28M | 6,075,028 |
| 16 | INVENTIVA SA | $28M | 4,974,906 |
| 17 | MBX BIOSCIENCES INC | $25M | 848,590 |
| 18 | AVALO THERAPEUTICS INC | $24M | 1,635,023 |
| 19 | ANIKA THERAPEUTICS INC | $21M | 1,435,130 |
| 20 | MAZE THERAPEUTICS INC | $18M | 614,962 |
| 21 | VERRICA PHARMACEUTICALS INC | $5M | 923,910 |
| 22 | SENSEI BIOTHERAPEUTICS INC | $4M | 126,002 |
| 23 | AURA BIOSCIENCES INC | $2M | 229,864 |
| 24 | XILIO THERAPEUTICS INC | $943k | 112,128 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.